Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial

類似資料

• Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate
  著者:: Joerger, Markus, 等
  出版事項: (2012)
• Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
  著者:: Ferreri, A J M, 等
  出版事項: (2004)
• Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
  著者:: Ferreri, Andrés J. M., 等
  出版事項: (2011)
• Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
  著者:: Verheijen, Remy B., 等
  出版事項: (2017)
• Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis
  著者:: Chládek, Jaroslav, 等
  出版事項: (2002)